Calamos Advisors’s Medpace MEDP Stock Holding History

Calamos Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,670	Closed	-$565K	–	689
2018 Q4	$565K	Buy	10,670 +3,800	+55%	+$209K	﹤0.01%	573
2018 Q3	$412K	Buy	+6,870	New	+$376K	﹤0.01%	612

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Calamos Advisors's MEDP Position: Q1 2019 in Review

Calamos Advisors sold out of Medpace (MEDP) in Q1 2019, closing a stake of 10,670 shares — an estimated $565K sold.

Calamos Advisors first reported a position in MEDP in Q3 2018 and held it in 2 quarters. The position peaked at $565K in Q4 2018. 231 funds tracked by Wall St. Rank hold MEDP as of Q1 2019.

Calamos Advisors reported no remaining Medpace position as of Q1 2019 after selling out during the quarter.
Calamos Advisors sold 10,670 Medpace shares in Q1 2019, an estimated $565K.
Calamos Advisors first reported a position in Medpace in Q3 2018 and held it in 2 quarters.
Calamos Advisors's Medpace position peaked at $565K in Q4 2018.
231 funds tracked by Wall St. Rank held Medpace as of Q1 2019.

Based on Calamos Advisors's 13F filing for Q1 2019, filed 12 Apr 2019.